NCT03611738 2026-02-09Ceritinib Plus Docetaxel in ALK-Negative, EGFR WT Advanced NSCLCH. Lee Moffitt Cancer Center and Research InstitutePhase 1 Active not recruiting21 enrolled
NCT02321501 2025-11-10Ceritinib and Everolimus in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIB-IV Non-small Cell Lung CancerM.D. Anderson Cancer CenterPhase 1 Active not recruiting37 enrolled